Singulex, Inc.’s Erenna® Single Molecule Counting Technology an Enabling Factor in Two Award Winning Studies Presented at the AACC Annual Meeting
7/31/2013 9:52:18 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ALAMEDA, Calif.--(BUSINESS WIRE)--Singulex, Inc., first to commercialize Single Molecule Counting (SMC) technology and committed to improving patient care and enabling the reduction of healthcare costs by providing high-value, advanced tests and systems for the diagnosis and monitoring of chronic diseases, today announced that the AACC has recognized two studies featuring Singulex’s Erenna® technology with the National Academy of Clinical Biochemistry’s Distinguished Abstract Award at its Annual Meeting being held in Houston, TX.
Help employers find you! Check out all the jobs and post your resume.
comments powered by